NEXT-GENERATION SEQUENCING IN CANCER
October 20th, 2021
With recent advancements in technology, genomic medicine is continuously becoming more accessible to clinicians worldwide. Next-Generation Sequencing (NGS) has become a widely implemented technique that allows cost-efficient sequencing of a high number of base nucleotides in a short time frame. With the use of NGS, gene alterations in various common diseases have become detectable and enabled the development of personalized pharmaceutics. Gene panels are utilized as a part of cancer genomic profiling in order to provide individual patients with an opportunity for optimal treatment depending on the aspect of their cancer type.